Added to the GeoSpecial list on January 7, 2010 @ $3.70
Catalyst: Was selling under book.
Peak performance: Reached a high of $4.89 on January 15, 2010.
Current Price: $2.41
Current road block: Dilution from recent financing; Guidance range leads to a wide range in EPS. On the low side EPS growth would be minimal. On the high side EPS growth would be around 30.0%; has failed to deliver consistent EPS growth.
Will keep CHME on the GeoSpecial on the Radar List to observe if the company can move towards the high end of its guidance. We will dig for more clues, but for the time being investors may view CHME as an unexciting option.
Note: We are still performing due diligence on the CHME share count which currently stands at 20,431,139.
PharmaDistribution
chinamedicine...